Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Trends in Cell Biology|September 26, 2022
Cut loose TIMP-1: an emerging cytokine in inflammationBenjamin Schoeps, Julian Frädrich, Achim KrügerTrends in Cell Biology|September 24, 2018
Recognizing the Molecular Multifunctionality and Interactome of TIMP-1Barbara Grünwald, Benjamin Schoeps, Achim KrügerOncogene|March 28, 2025
Deciphering permissivity of human tumor ecosystems to oncolytic virusesBenjamin Schoeps, Ulrich M Lauer, Knut ElbersCancer Metastasis Reviews|September 19, 2019
Functional disparities within the TIMP family in cancer: hints from molecular divergenceCelina Eckfeld, Daniel Häußler, Benjamin Schoeps, et al.Cancer Research|November 30, 2018
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer CellsArthur Dyer, Benjamin Schoeps, Sally Frost, et al.Journal of Cachexia, Sarcopenia and Muscle|February 16, 2021
A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patientsOlga Prokopchuk, Chris D Hermann, Benjamin Schoeps, et al.The Journal of Biological Chemistry|August 15, 2021
Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1)Benjamin Schoeps, Celina Eckfeld, Laura Flüter, et al.Cancer Research|May 4, 2021
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic CancerBenjamin Schoeps, Celina Eckfeld, Olga Prokopchuk, et al.The Journal of Cell Biology|January 11, 2023
TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytesCelina Eckfeld, Benjamin Schoeps, Daniel Häußler, et al.Molecular Therapy. Oncology|March 2, 2026
The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell linesRieka C Buchenau, Anne M Schiller, Julia Beil, et al.Pageof 2